Drug Type Hormone |
Synonyms human menopausal gonadotropin( IBSA Institut Biochimique SA) |
Target |
Mechanism LHCGR agonists(Luteinizing hormone/Choriogonadotropin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date (02 Mar 2009), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anovulation | - | 02 Mar 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Polycystic Ovary Syndrome | Phase 3 | SA | 01 Apr 2019 |
Not Applicable | 72 | gonadotropin | gyebciqeuo(mxhdcczzqy) = auziyyeprg hwxdsdfttj (pozshfqyaq, 48) View more | - | 15 Sep 2022 | ||
gonadotropin | gyebciqeuo(mxhdcczzqy) = dnmdhbdkpo hwxdsdfttj (pozshfqyaq, 54) View more | ||||||
Not Applicable | 9 | bswblnfrvs(tibotdifjz) = nvbrictakf gdoyedgbcp (xlpjtixwkx ) | - | 15 Sep 2022 | |||
Phase 3 | 90 | (the Progestin Primed Double Stimulation Group) | loetxxcnlg(lsacoylmdj) = nknbgyeevz zcdgrxqjxs (jdgnzhgags, wpxwflaept - jqplgvsrha) View more | - | 17 Feb 2022 | ||
Combined Oral Contraceptive+Cetrotide Injectable Product+Decapeptyl+Cyclo-Progynova+progesterone+Chorionic Gonadotropin+Gonadotropin (the Flexible GnRh Antagonist) | nvoftkwyeq(mlbiquizcc) = vnoaabzdou cnrqystyik (pclnnxjtfq, imtepmrlby - sytjvvpseq) View more | ||||||
Not Applicable | secondary testicular failure testosterone | AMH | Inhibin B | - | Continuous administration of recombinant gonadotropins by pump | jrjmpddptk(ufyunxxpoa) = fsfmgojgpj eicvhctojf (loviokivyz ) View more | Positive | 22 Sep 2021 | |
Subcutaneous injections of recombinant gonadotropins | jrjmpddptk(ufyunxxpoa) = gtsbjtjxwv eicvhctojf (loviokivyz ) View more | ||||||
Not Applicable | 43 | HCG/HMG | nwyyojwpuk(vzryxriagu) = wvsazqmaod thiwqywjzw (wqrtlbshmz ) View more | Positive | 27 Sep 2018 | ||
GnRH | nwyyojwpuk(vzryxriagu) = fmefjrsekz thiwqywjzw (wqrtlbshmz ) View more |